Quality of life in Parkinson's disease: The relative importance of the symptoms
Identifieur interne : 002662 ( Main/Exploration ); précédent : 002661; suivant : 002663Quality of life in Parkinson's disease: The relative importance of the symptoms
Auteurs : Shibley Rahman [Royaume-Uni] ; Harry J. Griffin [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-07-30.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Accidental Falls, Activities of Daily Living, Aged, Aged, 80 and over, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Anxiety (etiology), Anxiety (psychology), Cognition Disorders (etiology), Cognition Disorders (psychology), Depression, Depression (etiology), Depression (psychology), Disabled Persons (psychology), Dyskinesia, Drug-Induced (etiology), Dyskinesia, Drug-Induced (psychology), England (epidemiology), Female, Gait Disorders, Neurologic (etiology), Gait Disorders, Neurologic (psychology), Humans, Male, Middle Aged, Mobility, Nervous system diseases, Pain (etiology), Pain (psychology), Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson Disease (psychology), Parkinson disease, Parkinson's disease, Quality of Life, Quality of life, Questionnaires, Severity of Illness Index, Sleep Disorders, Intrinsic (etiology), Sleep Disorders, Intrinsic (psychology), Urinary Incontinence (etiology), Urinary Incontinence (psychology), depression., mobility, quality of life, symptoms.
- MESH :
- chemical , adverse effects : Antiparkinson Agents.
- chemical , therapeutic use : Antiparkinson Agents.
- geographic , epidemiology : England.
- complications : Parkinson Disease.
- drug therapy : Parkinson Disease.
- etiology : Anxiety, Cognition Disorders, Depression, Dyskinesia, Drug-Induced, Gait Disorders, Neurologic, Pain, Sleep Disorders, Intrinsic, Urinary Incontinence.
- psychology : Anxiety, Cognition Disorders, Depression, Disabled Persons, Dyskinesia, Drug-Induced, Gait Disorders, Neurologic, Pain, Parkinson Disease, Sleep Disorders, Intrinsic, Urinary Incontinence.
- Accidental Falls, Activities of Daily Living, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Quality of Life, Questionnaires, Severity of Illness Index.
Abstract
A body of literature now exists, which demonstrates that idiopathic Parkinson's disease (PD) has a major negative impact on quality of life (QoL), and that depression and cognitive impairment are among the main predictors of poor QoL in this disorder. Relatively little work has been done to assess the differential contribution of the specific symptoms of PD to QoL, which was the aim of this study. One hundred thirty patients with PD completed a booklet of questionnaires, which included the PDQ39 as a disease‐specific measure of QoL, a symptom checklist, a mobility checklist, as well as patient ratings of disease stage and disability. The results indicated that the contribution of physical, medication‐related, and cognitive/psychiatric symptoms to QoL can be significant. Sudden unpredictable on/off states, difficulty in dressing, difficulty in walking, falls, depression, and confusion were PD symptoms, which significantly influenced QoL scores. Among the mobility problems associated with PD, start hesitation, shuffling gait, freezing, festination, propulsion, and difficulty in turning had a significant effect on QoL scores. In addition to depression and anxiety, the major predictors of QoL were shuffling, difficulty turning, falls, difficulty in dressing, fatigue, confusion, autonomic disturbance particularly urinary incontinence, unpredictable on/off fluctuations, and sensory symptoms such as pain. The implications of these results for the medical management of PD are discussed. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21667
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001085
- to stream Istex, to step Curation: 001085
- to stream Istex, to step Checkpoint: 001218
- to stream PubMed, to step Corpus: 002200
- to stream PubMed, to step Curation: 002200
- to stream PubMed, to step Checkpoint: 002113
- to stream Ncbi, to step Merge: 002163
- to stream Ncbi, to step Curation: 002163
- to stream Ncbi, to step Checkpoint: 002163
- to stream Main, to step Merge: 003240
- to stream PascalFrancis, to step Corpus: 001176
- to stream PascalFrancis, to step Curation: 001B43
- to stream PascalFrancis, to step Checkpoint: 001113
- to stream Main, to step Merge: 003721
- to stream Main, to step Curation: 002662
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quality of life in Parkinson's disease: The relative importance of the symptoms</title><author><name sortKey="Rahman, Shibley" sort="Rahman, Shibley" uniqKey="Rahman S" first="Shibley" last="Rahman">Shibley Rahman</name></author><author><name sortKey="Griffin, Harry J" sort="Griffin, Harry J" uniqKey="Griffin H" first="Harry J." last="Griffin">Harry J. Griffin</name></author><author><name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P." last="Quinn">Niall P. Quinn</name></author><author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B03510CD9631A6190D7A2D0921C8FAE90374C50E</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.21667</idno><idno type="url">https://api.istex.fr/document/B03510CD9631A6190D7A2D0921C8FAE90374C50E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001085</idno><idno type="wicri:Area/Istex/Curation">001085</idno><idno type="wicri:Area/Istex/Checkpoint">001218</idno><idno type="wicri:doubleKey">0885-3185:2008:Rahman S:quality:of:life</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:18543333</idno><idno type="wicri:Area/PubMed/Corpus">002200</idno><idno type="wicri:Area/PubMed/Curation">002200</idno><idno type="wicri:Area/PubMed/Checkpoint">002113</idno><idno type="wicri:Area/Ncbi/Merge">002163</idno><idno type="wicri:Area/Ncbi/Curation">002163</idno><idno type="wicri:Area/Ncbi/Checkpoint">002163</idno><idno type="wicri:Area/Main/Merge">003240</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:08-0417068</idno><idno type="wicri:Area/PascalFrancis/Corpus">001176</idno><idno type="wicri:Area/PascalFrancis/Curation">001B43</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001113</idno><idno type="wicri:doubleKey">0885-3185:2008:Rahman S:quality:of:life</idno><idno type="wicri:Area/Main/Merge">003721</idno><idno type="wicri:Area/Main/Curation">002662</idno><idno type="wicri:Area/Main/Exploration">002662</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quality of life in Parkinson's disease: The relative importance of the symptoms</title><author><name sortKey="Rahman, Shibley" sort="Rahman, Shibley" uniqKey="Rahman S" first="Shibley" last="Rahman">Shibley Rahman</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Griffin, Harry J" sort="Griffin, Harry J" uniqKey="Griffin H" first="Harry J." last="Griffin">Harry J. Griffin</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P." last="Quinn">Niall P. Quinn</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-07-30">2008-07-30</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1428">1428</biblScope><biblScope unit="page" to="1434">1434</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">B03510CD9631A6190D7A2D0921C8FAE90374C50E</idno><idno type="DOI">10.1002/mds.21667</idno><idno type="ArticleID">MDS21667</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Accidental Falls</term><term>Activities of Daily Living</term><term>Aged</term><term>Aged, 80 and over</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Anxiety (etiology)</term><term>Anxiety (psychology)</term><term>Cognition Disorders (etiology)</term><term>Cognition Disorders (psychology)</term><term>Depression</term><term>Depression (etiology)</term><term>Depression (psychology)</term><term>Disabled Persons (psychology)</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Dyskinesia, Drug-Induced (psychology)</term><term>England (epidemiology)</term><term>Female</term><term>Gait Disorders, Neurologic (etiology)</term><term>Gait Disorders, Neurologic (psychology)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Mobility</term><term>Nervous system diseases</term><term>Pain (etiology)</term><term>Pain (psychology)</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (psychology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Quality of Life</term><term>Quality of life</term><term>Questionnaires</term><term>Severity of Illness Index</term><term>Sleep Disorders, Intrinsic (etiology)</term><term>Sleep Disorders, Intrinsic (psychology)</term><term>Urinary Incontinence (etiology)</term><term>Urinary Incontinence (psychology)</term><term>depression.</term><term>mobility</term><term>quality of life</term><term>symptoms</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>England</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Anxiety</term><term>Cognition Disorders</term><term>Depression</term><term>Dyskinesia, Drug-Induced</term><term>Gait Disorders, Neurologic</term><term>Pain</term><term>Sleep Disorders, Intrinsic</term><term>Urinary Incontinence</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Anxiety</term><term>Cognition Disorders</term><term>Depression</term><term>Disabled Persons</term><term>Dyskinesia, Drug-Induced</term><term>Gait Disorders, Neurologic</term><term>Pain</term><term>Parkinson Disease</term><term>Sleep Disorders, Intrinsic</term><term>Urinary Incontinence</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Accidental Falls</term><term>Activities of Daily Living</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Quality of Life</term><term>Questionnaires</term><term>Severity of Illness Index</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Etat dépressif</term><term>Maladie de Parkinson</term><term>Mobilité</term><term>Pathologie du système nerveux</term><term>Qualité de vie</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A body of literature now exists, which demonstrates that idiopathic Parkinson's disease (PD) has a major negative impact on quality of life (QoL), and that depression and cognitive impairment are among the main predictors of poor QoL in this disorder. Relatively little work has been done to assess the differential contribution of the specific symptoms of PD to QoL, which was the aim of this study. One hundred thirty patients with PD completed a booklet of questionnaires, which included the PDQ39 as a disease‐specific measure of QoL, a symptom checklist, a mobility checklist, as well as patient ratings of disease stage and disability. The results indicated that the contribution of physical, medication‐related, and cognitive/psychiatric symptoms to QoL can be significant. Sudden unpredictable on/off states, difficulty in dressing, difficulty in walking, falls, depression, and confusion were PD symptoms, which significantly influenced QoL scores. Among the mobility problems associated with PD, start hesitation, shuffling gait, freezing, festination, propulsion, and difficulty in turning had a significant effect on QoL scores. In addition to depression and anxiety, the major predictors of QoL were shuffling, difficulty turning, falls, difficulty in dressing, fatigue, confusion, autonomic disturbance particularly urinary incontinence, unpredictable on/off fluctuations, and sensory symptoms such as pain. The implications of these results for the medical management of PD are discussed. © 2007 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Rahman, Shibley" sort="Rahman, Shibley" uniqKey="Rahman S" first="Shibley" last="Rahman">Shibley Rahman</name></region><name sortKey="Griffin, Harry J" sort="Griffin, Harry J" uniqKey="Griffin H" first="Harry J." last="Griffin">Harry J. Griffin</name><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name><name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P." last="Quinn">Niall P. Quinn</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002662 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002662 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B03510CD9631A6190D7A2D0921C8FAE90374C50E
|texte= Quality of life in Parkinson's disease: The relative importance of the symptoms
}}
| This area was generated with Dilib version V0.6.23. |  |